BindingDB logo
myBDB logout

BDBM50445037 CHEMBL3098704

SMILES: [#6]-[#6@@H](-[#8])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#8]P([#8])([#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](-[#6])=O)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-n1cc(-[#6]-[#16]-[#6]-[#6]-[#7]-[#6](=O)-[#6]-[#6]-[#7]-[#6](=O)-[#6@@H](-[#8])C([#6])([#6])[#6]-[#8]P([#8])(=O)[#8]P([#8])(=O)[#8]-[#6]-[#6@H]-2-[#8]-[#6@H](-[#6@H](-[#8])-[#6@@H]-2-[#8]P([#8])([#8])=O)-n2cnc3c(-[#7])ncnc23)nn1)-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](-[#7])=O

InChI Key: InChIKey=JZNBESDGRVANJA-VSTLQYSKSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50445037   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone acetyltransferase PCAF


(Homo sapiens (Human))
BDBM50445037
PNG
(CHEMBL3098704)
Show SMILES [#6]-[#6@@H](-[#8])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#8]P([#8])([#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](-[#6])=O)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-n1cc(-[#6]-[#16]-[#6]-[#6]-[#7]-[#6](=O)-[#6]-[#6]-[#7]-[#6](=O)-[#6@@H](-[#8])C([#6])([#6])[#6]-[#8]P([#8])(=O)[#8]P([#8])(=O)[#8]-[#6]-[#6@H]-2-[#8]-[#6@H](-[#6@H](-[#8])-[#6@@H]-2-[#8]P([#8])([#8])=O)-n2cnc3c(-[#7])ncnc23)nn1)-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](-[#7])=O |r|
Show InChI InChI=1S/C78H137N31O34P4S/c1-41(96-44(4)111)65(118)100-49(19-13-25-89-76(83)84)68(121)101-48(17-8-11-24-80)69(122)103-51(35-138-144(128,129)130)70(123)104-57(43(3)110)72(125)92-32-55(113)91-33-56(114)98-47(66(119)97-42(2)74(127)108-30-15-21-52(108)71(124)102-50(20-14-26-90-77(85)86)67(120)99-46(63(82)117)16-7-10-23-79)18-9-12-29-107-34-45(105-106-107)37-148-31-28-87-54(112)22-27-88-73(126)61(116)78(5,6)38-140-147(136,137)143-146(134,135)139-36-53-60(142-145(131,132)133)59(115)75(141-53)109-40-95-58-62(81)93-39-94-64(58)109/h34,39-43,46-53,57,59-61,75,110,115-116H,7-33,35-38,79-80H2,1-6H3,(H2,82,117)(H,87,112)(H,88,126)(H,91,113)(H,92,125)(H,96,111)(H,97,119)(H,98,114)(H,99,120)(H,100,118)(H,101,121)(H,102,124)(H,103,122)(H,104,123)(H,134,135)(H,136,137)(H2,81,93,94)(H4,83,84,89)(H4,85,86,90)(H2,128,129,130)(H2,131,132,133)/t41-,42-,43+,46-,47-,48-,49-,50-,51-,52-,53+,57-,59+,60+,61+,75+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.70E+3n/an/an/an/an/an/a



Utrecht University

Curated by ChEMBL


Assay Description
Inhibition of PCAF (unknown origin) using histone H3 derived peptide as substrate after 20 mins by fluorescence assay


Bioorg Med Chem Lett 24: 113-6 (2013)


Article DOI: 10.1016/j.bmcl.2013.11.060
BindingDB Entry DOI: 10.7270/Q2WD4222
More data for this
Ligand-Target Pair
Histone acetyltransferase PCAF


(Homo sapiens (Human))
BDBM50445037
PNG
(CHEMBL3098704)
Show SMILES [#6]-[#6@@H](-[#8])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#8]P([#8])([#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](-[#6])=O)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-n1cc(-[#6]-[#16]-[#6]-[#6]-[#7]-[#6](=O)-[#6]-[#6]-[#7]-[#6](=O)-[#6@@H](-[#8])C([#6])([#6])[#6]-[#8]P([#8])(=O)[#8]P([#8])(=O)[#8]-[#6]-[#6@H]-2-[#8]-[#6@H](-[#6@H](-[#8])-[#6@@H]-2-[#8]P([#8])([#8])=O)-n2cnc3c(-[#7])ncnc23)nn1)-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](-[#7])=O |r|
Show InChI InChI=1S/C78H137N31O34P4S/c1-41(96-44(4)111)65(118)100-49(19-13-25-89-76(83)84)68(121)101-48(17-8-11-24-80)69(122)103-51(35-138-144(128,129)130)70(123)104-57(43(3)110)72(125)92-32-55(113)91-33-56(114)98-47(66(119)97-42(2)74(127)108-30-15-21-52(108)71(124)102-50(20-14-26-90-77(85)86)67(120)99-46(63(82)117)16-7-10-23-79)18-9-12-29-107-34-45(105-106-107)37-148-31-28-87-54(112)22-27-88-73(126)61(116)78(5,6)38-140-147(136,137)143-146(134,135)139-36-53-60(142-145(131,132)133)59(115)75(141-53)109-40-95-58-62(81)93-39-94-64(58)109/h34,39-43,46-53,57,59-61,75,110,115-116H,7-33,35-38,79-80H2,1-6H3,(H2,82,117)(H,87,112)(H,88,126)(H,91,113)(H,92,125)(H,96,111)(H,97,119)(H,98,114)(H,99,120)(H,100,118)(H,101,121)(H,102,124)(H,103,122)(H,104,123)(H,134,135)(H,136,137)(H2,81,93,94)(H4,83,84,89)(H4,85,86,90)(H2,128,129,130)(H2,131,132,133)/t41-,42-,43+,46-,47-,48-,49-,50-,51-,52-,53+,57-,59+,60+,61+,75+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.30E+4n/an/an/an/an/an/a



Utrecht University

Curated by ChEMBL


Assay Description
Competitive inhibition of PCAF (unknown origin) using histone H3 derived peptide as substrate after 20 mins by fluorescence assay


Bioorg Med Chem Lett 24: 113-6 (2013)


Article DOI: 10.1016/j.bmcl.2013.11.060
BindingDB Entry DOI: 10.7270/Q2WD4222
More data for this
Ligand-Target Pair